Selective Endocytic Uptake of Targeted Liposomes Occurs within a Narrow Range of Liposome Diameters.

TIRF microscopy clathrin-mediated endocytosis drug-carrier internalization liposome targeted delivery

Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
01 Nov 2023
Historique:
medline: 2 11 2023
pubmed: 20 10 2023
entrez: 20 10 2023
Statut: ppublish

Résumé

Cell surface receptors facilitate signaling and nutrient uptake. These processes are dynamic, requiring receptors to be actively recycled by endocytosis. Due to their differential expression in disease states, receptors are often the target of drug-carrier particles, which are adorned with ligands that bind specifically to receptors. These targeted particles are taken into the cell by multiple routes of internalization, where the best-characterized pathway is clathrin-mediated endocytosis. Most studies of particle uptake have utilized bulk assays rather than observing individual endocytic events. As a result, the detailed mechanisms of particle uptake remain obscure. To address this gap, we employed a live-cell imaging approach to study the uptake of individual liposomes as they interact with clathrin-coated structures. By tracking individual internalization events, we find that the size of liposomes rather than the density of the ligands on their surfaces primarily determines their probability of uptake. Interestingly, targeting has the greatest impact on endocytosis of liposomes of intermediate diameters, with the smallest and largest liposomes being internalized or excluded, respectively, regardless of whether they are targeted. These findings, which highlight a previously unexplored limitation of targeted delivery, can be used to design more effective drug carriers.

Identifiants

pubmed: 37862704
doi: 10.1021/acsami.3c09399
doi:

Substances chimiques

Liposomes 0
Drug Carriers 0
Clathrin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

49988-50001

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM139531
Pays : United States

Commentaires et corrections

Type : UpdateOf

Auteurs

Grant Ashby (G)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.

Kayla E Keng (KE)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.

Carl C Hayden (CC)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.

Sadhana Gollapudi (S)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.

Justin R Houser (JR)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.

Sabah Jamal (S)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.

Jeanne C Stachowiak (JC)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.
Department of Chemical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.

Articles similaires

Adenosine Triphosphate Adenosine Diphosphate Mitochondrial ADP, ATP Translocases Binding Sites Mitochondria

Mutational analysis of Phanerochaete chrysosporium´s purine transporter.

Mariana Barraco-Vega, Manuel Sanguinetti, Gabriela da Rosa et al.
1.00
Phanerochaete Fungal Proteins Purines Aspergillus nidulans DNA Mutational Analysis

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers
Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin

Classifications MeSH